FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Wyeth related Press Releases

Prolong's Large Scale Manufacturing of Sickle Cell Product to be Headed by Industry Veteran

Posted December 15, 2011

SOUTH PLAINFIELD, N.J., Dec. 15, 2011 /PRNewswire/ -- Prolong Pharmaceuticals today announced that Tom Flachmeyer has joined Prolong to spearhead the firms' engineering and facilities planning Read more...

APP Pharmaceuticals Announces Approval of Nafcillin for Injection, USP

Posted July 6, 2011

SCHAUMBURG, Ill.--(BUSINESS WIRE)-- APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Read more...

Nuron Biotech Acquires Assets Related to HibTITER® Conjugate Vaccine

Posted April 6, 2011

EXTON, Penn.--(BUSINESS WIRE)-- Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has acquired assets relating to the vaccine HibTITER® (Haemophilus b Conjugate Read more...

Health Care M&A Activity for 2010 Remains Strong According to New Report from Irving Levin Associates, Inc.

Posted January 20, 2011

NORWALK, Conn.--(BUSINESS WIRE)-- During 2010 and based on preliminary results, a total of 913 mergers and acquisitions were announced in 13 sectors of the health care industry, a 3% decrease from Read more...

Santaris Pharma A/S Announces Expanded Worldwide Strategic Alliance With Pfizer Inc. Directed to Development of RNA-targeted Med

Posted January 4, 2011

- Pfizer to make payment of $14 million for access to Santaris Pharma A/S Locked Nucleic Acid (LNA) Drug Platform to develop RNA-targeted drugsHOERSHOLM, Denmark and SAN DIEGO, Jan. 4, 2011 Read more...

ClinTec Strengthens US Operations with the Appointment of New Executive Vice President, Dr Dianne Kikta

Posted September 28, 2010

GLASGOW, Scotland--(BUSINESS WIRE)-- UK-based global Clinical Research Organisation (CRO), ClinTec International has further established its US presence with the appointment of new Executive Vice Read more...

Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network

Posted May 18, 2010

Eight Sites Targeted for Exit; Reductions Recommended At Six Plants; Operations to Expand at OthersNEW YORK, May 18 /PRNewswire-FirstCall/ -- Pfizer Global Manufacturing announced today plans to Read more...

Pfizer Reports First-Quarter 2010 Results; Reaffirms 2010 Financial Guidance

Posted May 4, 2010

NEW YORK May 4 /PRNewswire-FirstCall/ --First-Quarter 2010 Revenues of $16.8 BillionFirst-Quarter 2010 Reported Diluted EPS(1) of $0.25, Adjusted Diluted EPS(2) of $0.60Reaffirms 2010 Financial Read more...

Bio-Pharma Industry Experts Deliver M&A Value Through Integration Excellence

Posted April 28, 2010

CHAPEL HILL, N.C., April 28 /PRNewswire/ -- The biopharma mega-mergers that grabbed headlines last year - Roche + Genentech, Pfizer + Wyeth and Merck + Schering-Plough - are now in the critical Read more...

NICE rejects appeal against decision to deny Torisel® (temsirolimus) to NHS patients in England & Wales

Posted August 26, 2009

NICE rejects appeal against decision to deny Torisel (temsirolimus) to NHS patients in England & Wales Taplow, UK, 26 August 2009:- The most severely ill advanced renal cell cancer patients in Read more...
12345next ›last »